Active, not recruitingPhase 2NCT05039840
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
Studying Systemic lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sanofi
- Principal Investigator
- Clinical Sciences & OperationsSanofi
- Intervention
- SAR441344 IV(drug)
- Enrollment
- 109 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2021 – 2026
Study locations (30)
- Accel Research Sites Network - Birmingham- Site Number : 8400003, Vestavia Hills, Alabama, United States
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler- Site Number : 8400026, Chandler, Arizona, United States
- Arizona Arthritis & Rheumatology Associates - South Vineyard Avenue- Site Number : 8400022, Mesa, Arizona, United States
- Arizona Arthritis & Rheumatology Research - Sun City- Site Number : 8400027, Sun City, Arizona, United States
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson Southeast- Site Number : 8400023, Tucson, Arizona, United States
- Saint John's Physician Partners- Site Number : 8400015, Santa Monica, California, United States
- Millennium Clinical Trials - Simi Valley- Site Number : 8400004, Simi Valley, California, United States
- Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8400002, DeBary, Florida, United States
- Vitalia Medical Research - Margate- Site Number : 8400039, Margate, Florida, United States
- Innovia Research Center- Site Number : 8400037, Miramar, Florida, United States
- Integral Rheumatology and Immunology Specialists- Site Number : 8400014, Plantation, Florida, United States
- Infigo Clinical Research- Site Number : 8400016, Sanford, Florida, United States
- Inspire Santa Fe Medical Group- Site Number : 8400019, Santa Fe, New Mexico, United States
- Columbia University Irving Medical Center- Site Number : 8400009, New York, New York, United States
- RAO - Rheumatology Associates of Oklahoma- Site Number : 8400013, Oklahoma City, Oklahoma, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05039840 on ClinicalTrials.govOther trials for Systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07107659Safety and Efficacy of ONT01 in LupusHospital for Special Surgery, New York
- RECRUITINGNANCT07558850Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNCT06948110Deciphering the Genetic Architecture of Autoimmune DiseasesNational Human Genome Research Institute (NHGRI)
- RECRUITINGPHASE2NCT07409181A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Boehringer Ingelheim
- RECRUITINGPHASE3NCT07332481A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseEMD Serono Research & Development Institute, Inc.
- RECRUITINGEARLY PHASE1NCT07526350MTS109 in Patients With Refractory Autoimmune DiseasesShanghai Changzheng Hospital
- RECRUITINGEARLY PHASE1NCT07490041Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic DiseasesThe Children's Hospital of Zhejiang University School of Medicine
- RECRUITINGNANCT07470151Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology